08.22.24 -- Umoja Biopharma's Potential For First In Vivo CAR T To Enter Clinic

Single-use tubular bowl centrifuges are standing out to cell therapy developers for their ability enable the optimal balance between high separation efficiency, high productivity, and low shear.

If you're a CGT manufacturing company transitioning to automation, consider the strategies and manufacturing roadmap provided herein and how they can improve efficiencies in development.

Vaccine development can be complex and expensive. Improving your development process through reduced costs and increased efficiencies may be vital for your success. Peptones can offer a solution. 

Insights from leading experts highlight the potential of the rapidly evolving field of psychedelic therapies and underscore the importance of clinical trials and regulatory compliance.

Cell and gene therapies hold tremendous promise for patients with advanced cancers and genetic diseases. Here, experts provide tips designed to accelerate development and market entry.

Uncover one of the best ways to ensure sterility in aseptic compounding operations and how 503A and 503B pharmacies can achieve the adaptability they need to scale their operation.

Review the results of a study comparing mass photometry and CDMS techniques for their ability to distinguish AAV loading distributions and evaluate adeno-associated virus (AAV) capsid content.

See why single-use cold-chain containers made with polytetrafluoroethylene fluoropolymers may be less susceptible to failure and breakage at cold temperatures.

In this study, we demonstrate the ability of animal component-free Insti CHO and HEK cell culture supplements to overcome cell culture limitations while meeting regulatory requirements.

Discover a comprehensive, modular, and functionally closed end-to-end solution designed for the efficient and scalable manufacture of autologous CAR T cell therapies.

Learn how leveraging an LVV platform can provide a fast track to GMP manufacturing, regulatory support, process characterization and validation activities to support commercialization, and more.

Gain insights into the development of products that address the lack of consistent reference material for cell-based assays in drug development and their evolution into a successful solution.